Effect of the XbaI polymorphism of estrogen receptor alpha on postmenopausal gray matter

Neuroscience Letters

Volumn 434, Issue 3, 2008, Pages 304-309

  Boccardi, Marina ^a   Scassellati, Catia ^a   Ghidoni, Roberta ^a   Testa, Cristina ^a,b   Benussi, Luisa ^a   Bonetti, Matteo ^c   Bocchio Chiavetto, Luisella ^a   Gennarelli, Massimo ^a,d   Binetti, Giuliano ^a   Frisoni, Giovanni B ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c Istituto Clinico Citta di Brescia   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Estrogen receptor alpha; Morphometry; MR; Neuroimaging; VBM; XbaI

Indexed keywords

ESTROGEN RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GRAY MATTER; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; POSTMENOPAUSE; PRIORITY JOURNAL; XBAI GENE;

ALZHEIMER DISEASE; ATROPHY; BRAIN; COGNITION DISORDERS; CYTOPROTECTION; DEMENTIA; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POSTMENOPAUSE;

EID: 40849115969     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.01.076     Document Type: Article

References (35)

1. Allen G., Barnard H., McColl R., Hester A.L., Fields J.A., Weiner M.F., Ringe W.K., Lipton A.M., Brooker M., McDonald E., Rubin C.D., and Cullum C.M. Reduced hippocampal functional connectivity in Alzheimer disease. Arch. Neurol. 64 (2007) 1482-1487
2. Becherini L., Gennari L., Masi L., Mansani R., Massart F., Morelli A., Falchetti A., Gonnelli S., Fiorelli G., Tanini A., and Brandi M.L. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum. Mol. Genet. 9 (2000) 2043-2050
3. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39 (2007) 17-23
4. Boccardi M., Ghidoni R., Govoni S., Testa C., Benussi L., Bonetti M., Binetti G., and Frisoni G.B. Effects of hormone therapy on brain morphology of healthy postmenopausal women: a voxel-based morphometry study. Menopause 13 (2006) 584-591
5. Brandi M.L., Becherini L., Gennari L., Racchi M., Bianchetti A., Nacmias B., Sorbi S., Mecocci P., Senin U., and Govoni S. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem. Biophys. Res. Commun. 265 (1999) 335-338
6. Corbo R.M., Gambina G., Ruggeri M., and Scacchi R. Association of estrogen receptor alpha (ESR1) PvuII and XbaI polymorphisms with sporadic Alzheimer's disease and their effect on apolipoprotein E concentrations. Dement. Geriatr. Cogn. Disord. 22 (2006) 67-72
7. den Heijer T., Schuit S.C., Pols H.A., van Meurs J.B., Hofman A., Koudstaal P.J., van Duijn C.M., Uitterlinden A.G., and Breteler M.M. Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. Mol. Psychiatry 9 (2004) 1129-1135
8. Friston K.J., Glaser D.E., Henson R.N., Kiebel S., Phillips C., and Ashburner J. Classical and Bayesian inference in neuroimaging: applications. Neuroimage 16 (2002) 484-512
9. Friston K.J., Penny W., Phillips C., Kiebel S., Hinton G., and Ashburner J. Classical and Bayesian inference in neuroimaging: theory. Neuroimage 16 (2002) 465-483
10. Ghidoni R., Boccardi M., Benussi L., Testa C., Villa A., Pievani M., Gigola L., Sabattoli F., Barbiero L., Frisoni G.B., and Binetti G. Effects of estrogens on cognition and brain morphology: involvement of the cerebellum. Maturitas 54 (2006) 222-228
11. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 (1990) 545-548
12. Ioannidis J.P., Ralston S.H., Bennett S.T., Brandi M.L., Grinberg D., Karassa F.B., Langdahl B., van Meurs J.B., Mosekilde L., Scollen S., Albagha O.M., Bustamante M., Carey A.H., Dunning A.M., Enjuanes A., van Leeuwen J.P., Mavilia C., Masi L., McGuigan F.E., Nogues X., Pols H.A., Reid D.M., Schuit S.C., Sherlock R.E., and Uitterlinden A.G. GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292 (2004) 2105-2014
13. Isoe K., Ji Y., Urakami K., Adachi Y., and Nakashima K. Genetic association of estrogen receptor gene polymorphisms with Alzheimer's disease. Alzheimer Res. 3 (1997) 195-197
14. Isoe-Wada K., Maeda M., Yong J., Adachi Y., Harada H., Urakami K., and Nakashima K. Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia. Eur. J. Neurol. 6 (1999) 431-435
15. Ji Y., Urakami K., Wada-Isoe K., Adachi Y., and Nakashima K. Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia. Dement. Geriatr. Cogn. Disord. 11 (2000) 119-122
16. Kazama H., Ruberu N.N., Murayama S., Saito Y., Nakahara K., Kanemaru K., Nagura H., Arai T., Sawabe M., Yamanouchi H., Orimo H., and Hosoi T. Association of estrogen receptor alpha gene polymorphisms with neurofibrillary tanglesm. Dement. Geriatr. Cogn. Disord. 18 (2004) 145-150
17. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., and Orimo H. Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res. 11 (1996) 306-311
18. Kritzer M.F. Regional, laminar and cellular distribution of immunoreactivity for ERbeta in the cerebral cortex of hormonally intact, postnatally developing male and female rats. Cereb. Cortex 16 (2006) 1181-1192
19. Lambert J.C., Harris J.M., Mann D., Lemmon H., Coates J., Cumming A., St-Clair D., and Lendon C. Are the estrogen receptors involved in Alzheimer's disease?. Neurosci. Lett. 306 (2001) 193-197
20. Lehtovirta M., Laakso M.P., Frisoni G.B., and Soininen H. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol. Aging 21 (2000) 293-300
21. Lin G.F., Ma Q.W., Zhang D.S., Zha Y.L., Lou K.J., and Shen J.H. Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb. Acta Pharmacol. Sin. 24 (2003) 651-656
22. Maruyama H., Toji H., Harrington C.R., Sasaki K., Izumi Y., Ohnuma T., Arai H., Yasuda M., Tanaka C., Emson P.C., Nakamura S., and Kawakami H. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch. Neurol. 57 (2000) 236-240
23. Mattila K.M., Axelman K., Rinne J.O., Blomberg M., Lehtimaki T., Laippala P., Roytta M., Viitanen M., Wahlund L., Winblad B., and Lannfelt L. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci. Lett. 282 (2000) 45-48
24. Mitra S., Desai M., and Khatkhatay M.I. Association of estrogen receptor alpha gene polymorphisms with bone mineral density in postmenopausal Indian women. Mol. Genet. Metab. 87 (2006) 80-87
25. Monastero R., Cefalu A.B., Camarda C., Noto D., Camarda L.K., Caldarella R., Imbornone E., Averna M.R., and Camarda R. Association of estrogen receptor alpha gene with Alzheimer's disease: a case-control study. J. Alzheimer's Dis. 9 (2006) 273-278
26. Nichols T.E., and Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 15 (2002) 1-25
27. Olsen L., Rasmussen H.B., Hansen T., Bagger Y.Z., Tanko L.B., Qin G., Christiansen C., and Werge T. Estrogen receptor alpha and risk for cognitive impairment in postmenopausal women. Psychiatr. Genet. 16 (2006) 85-88
28. Osterlund M.K., and Hurd Y.L. Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog. Neurobiol. 64 (2001) 251-267
29. Porrello E., Monti M.C., Sinforiani E., Cairati M., Guaita A., Montomoli C., Govoni S., and Racchi M. Estrogen receptor alpha and APOE epsilon4 polymorphisms interact to increase risk for sporadic AD in Italian females. Eur. J. Neurol. 13 (2006) 639-644
30. Rapuri P.B., Gallagher J.C., Knezetic J.A., and Haynatzka V. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen. Maturitas 53 (2006) 371-379
31. Stirone C., Duckles S.P., and Krause D.N. Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am. J. Physiol. Endocrinol. Metab. 284 (2003) 184-192
32. Usui C., Shibata N., Ohnuma T., Higashi S., Ohkubo T., Ueki A., Nagao M., and Arai H. No genetic association between the myeloperoxidase gene-463 polymorphism and estrogen receptor-alpha gene polymorphisms and Japanese sporadic Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 21 (2006) 296-299
33. van Duijnhoven F.J., Bezemer I.D., Peeters P.H., Higashi S., Ohkubo T., Ueki A., Nagao M., and Arai H. Polymorphisms in the estrogen receptor alpha gene and mammographic density, Cancer Epidemiol. Biomarkers Prev. 14 (2005) 2655-2660
34. van Duijnhoven F.J., Peeters P.H., Warren R.M., Bingham S.A., Uitterlinden A.G., van Noord P.A., Monninkhof E.M., Grobbee D.E., and van Gils C.H. Influence of estrogen receptor alpha and progesterone receptor polymorphisms on the effects of hormone therapy on mammographic density. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 462-467
35. Yaffe K., Lui L.Y., Grady D., Stone K., and Morin P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol. Psychiatry 51 (2002) 677-682